Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
174 StokerM.GherardiE.PerrymanM.GrayJ
10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
doi: 10.1093/advances/nmy055 [PMC free article] [PubMed] [CrossRef] [Google Scholar] Otto C.M., Heartbeat: weight loss interventions in patients with cardiovascular disease
The MHRA recommends monitoring B12 levels in patients on long-term metformin treatment
